Pulished Date August, 2019
ID: 6190
Share on
Share on

Thin Film Drugs Market Segmented By Product, By Disease Indication, By Distribution Channel, And By Region - Global Growth, Trends, And Forecast To 2024

Pulished: August, 2019
ID: 6190
Pages: 175

Thin Film Drugs Market Drivers and Restraints:

Thin Film Drugs Market By Product (Oral Thin Film (Sublingual Film And Fully Dissolving Dental/Buccal Film), And Transdermal Thin Film), Disease Indication (Schizophrenia, Migraine, Opioid Dependence, And Nausea And Vomiting), Distribution Channel (Hospital Pharmacies, Drug Store, Retail Pharmacies, And E-Commerce), And Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023.

Thin Film Drugs market is anticipated to grow at 9.00% CAGR from 2018 to 2023 and it is estimated that the global market was valued at USD 18.98 billion in 2018 and is expected to reach USD 29.2 billion by 2023.

Thin film drugs are made of hydrophilic polymers that readily dissolve on the buccal cavity. These drugs are administered orally and enter the systemic circulation of the body upon absorption on the tongue.

The growing demand for efficient drug delivery systems has amplified the uptake of thin film drugs due to their efficiency and effectiveness. The convenience of transportation and storage has encouraged patients to opt for these drugs. Thin film drugs also permit precise dosages to accomplish desired outcomes and thereby aid the market growth. The growing investments in research and development of newer polymeric thin films as a method of drug deliver has also invigorated the market growth. Thin film drugs are poised to gain attention in the healthcare industry as eliminate the drawbacks associated with conventional forms of dosages such as inconvenience of administration, lower bioavailability, and patient non-compliance among others.

The global Thin Film Drugs market is segmented on the basis of Product, Disease Indication and Distribution Channel. On the basis of Product, the market is segmented into Oral Thin Film, and Transdermal Thin Film. The Oral Thin Film sub segment is further segmented into Sublingual Film and Fully Dissolving Dental/Buccal Film. In 2017, the oral thin film sub segment held the largest share of the Product market segment followed by transdermal thin film. On the basis of Disease Indication, the market is segmented into Schizophrenia, Migraine, Opioid Dependence, and Nausea and Vomiting. On the basis of Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Store, Retail Pharmacies, and E-Commerce.

On the basis of geography, the Thin Film Drugs market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America accounted for the largest share of the Thin Film Drugs market owing to factors such as advancements in pharmaceutical research coupled with extensive investments in research and development. Moreover, a steadily rising demand of novel drug delivery is further expected to aid the growth of the regional market.

The market is dominated by companies like Pfizer Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc., Sumitomo Dainippon Pharma Co. Ltd., Indivior Plc., MonoSol Rx, IntelGenx Corp., ZIM Laboratories Limited, and IntelGenx Corp.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Oral Thin Film         

                                       Sublingual Film

                                       Fully Dissolving Dental/Buccal Film

                                5.1.3 Transdermal Thin Film        

                                5.1.4 Y-o-Y Growth Analysis, By Product               

                                5.1.5 Market Attractiveness Analysis, By Product             

                                5.1.6 Market Share Analysis, By Product               

                5.2 Disease Indication                   

                                5.2.1 Introduction           

                                5.2.2 Schizophrenia        

                                5.2.3 Migraine  

                                5.2.4 Opioid Dependence            

                                5.2.5 Nausea and Vomiting         

                                5.2.6 Y-o-Y Growth Analysis, By Disease Indication           

                                5.2.7 Market Attractiveness Analysis, By Disease Indication         

                                5.2.8 Market Share Analysis, By Disease Indication          

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Drug Store               

                                5.3.4 Retail Pharmacies

                                5.3.5 E-Commerce          

                                5.3.6 Others      

                                5.3.7 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.8  Market Attractiveness Analysis, By Distribution Channel   

                                5.3.9  Market Share Analysis, By Distribution Channel     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Product

                                       By Disease Indication

                                       By Distribution Channel

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area

                                       By Product

                                       By Disease Indication

                                       By Distribution Channel

                                6.1.5  Market Share Analysis      

                                       By Geographical Area

                                       By Product

                                       By Disease Indication

                                       By Distribution Channel

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Novartis AG                

                8.3 Wolters Kluwer                         

                8.4 Solvay                           

                8.5 Allergan plc.                               

                8.6 Sumitomo Dainippon Pharma Co. Ltd.                            

                8.7 Indivior Plc.                 

                8.8 MonoSol Rx                

                8.9 IntelGenx Corp.                        

                8.10 ZIM Laboratories Limited                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms Distribution Channel  along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Thin Film Drugs  Market By Region, From 2019-2024 ( USD Billion )
  2. Global Thin Film Drugs  Market By Product, From 2019-2024 ( USD Billion )
  3. Global Oral Thin Film Market By Region, From 2019-2024 ( USD Billion )
  4. Global Transdermal Thin Film Market By Region, From 2019-2024 ( USD Billion )
  5. Global Thin Film Drugs  Market By Disease Indication, From 2019-2024 ( USD Billion )
  6. Global Schizophrenia Market By Region, From 2019-2024 ( USD Billion )
  7. Global Migraine Market By Region, From 2019-2024 ( USD Billion )
  8. Global Opioid Dependence Market By Region, From 2019-2024 ( USD Billion )
  9. Global Nausea and Vomiting Market By Region, From 2019-2024 ( USD Billion )
  10. Global Thin Film Drugs  Market By Distribution Channel, From 2019-2024 ( USD Billion )
  11. Global Hospital Pharmacies Market By Region, From 2019-2024 ( USD Billion )
  12. Global Drug Store Market By Region, From 2019-2024 ( USD Billion )
  13. Global Retail Pharmacies  Market By Region, From 2019-2024 ( USD Billion )
  14. Global E-Commerce Market By Region, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed


$ 1234 4255

Click for Request Sample